TrialAntimicrobial agents and chemotherapy2015

Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities.

B Hafkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.